Alzamend Neuro Stock Quote ALZN - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

3.5294

Bid

3.52

Ask

3.56

Volume

12,021

3.27 Day's Range 3.75

0.3691 52 Week Range 7.80

Market Cap

2.969M

Previous Close

3.72

Open

3.75

Last Trade

3.52

Last Trade Time

15:50:58

Financial Volume

$ 41,574

VWAP

3.4584

Average Volume (3m)

92,761

Shares Outstanding

798,176

Dividend Yield

PE Ratio

-0.19

Earnings Per Share (EPS)

-18.64

Revenue

Net Profit

-14.88M

Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipe... Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.alzamend.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Alzamend Neuro Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ALZN. The last closing price for Alzamend Neuro was $3.72. Over the last year, Alzamend Neuro shares have traded in a share price range of $ 0.3691 to $ 7.80.

Alzamend Neuro currently has 798,176 shares outstanding. The market capitalization of Alzamend Neuro is $2.97 million. Alzamend Neuro has a price to earnings ratio (PE ratio) of -0.19.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	3.1299	783.454317897	0.3995	4.42	0.37075	55116	1.64587779	CS
4	3.1154	752.512077295	0.414	4.42	0.3691	68078	0.69453716	CS
12	2.7794	370.586666667	0.75	4.42	0.3691	92761	0.58813333	CS
26	2.6295	292.199133237	0.8999	4.42	0.3691	71249	0.75220929	CS
52	-3.6871	-51.0926349338	7.2165	7.8	0.3691	133883	2.35773226	CS
156	-85.8706	-96.0521252796	89.4	124.2	0.3691	1096639	35.62804	CS
260	-431.4706	-99.1886436782	435	503.25	0.3691	1135578	41.74098207	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAGRAfrican Agriculture Holdings Inc	$ 0.00 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 0.00 (0.00%)	0
AADIAadi Bioscience Inc	$ 0.00 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 0.00 (0.00%)	0
AACGATA Creativity Global	$ 0.00 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.00 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 0.00 (0.00%)	0
AADIAadi Bioscience Inc	$ 0.00 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 0.00 (0.00%)	0
AACGATA Creativity Global	$ 0.00 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.00 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 0.00 (0.00%)	0
AADIAadi Bioscience Inc	$ 0.00 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 0.00 (0.00%)	0
AACGATA Creativity Global	$ 0.00 (0.00%)	0